Aspirin reduces risk for HCC in chronic hepatitis B

For patients with chronic hepatitis B, aspirin therapy correlated with a reduced risk for hepatocellular carcinoma, according to a presenter at The Liver Meeting Digital Experience.“Cirrhosis had a significant effect on the association between use of aspirin and the risk of HCC development,” Heejoon Jang, MD, from the department of internal medicine and Liver Research Institute, Seoul National University Hospital, said during his presentation.Using the Korean National Health insurance database, Jang and colleagues identified 329,635 adult patients with chronic hepatitis B; 20,200Read More

Share on facebook
Share on twitter
Share on linkedin